CLINICAL TRIAL
Accepted on 28 Jan 2025
Neoadjuvant Sintilimab and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
doi 10.3389/fimmu.2025.1486275
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Medicine and Targeted Therapies in Gastrointestinal and Genitourinary Solid Tumors
Precision Medicine and Targeted Therapies in Gastrointestinal and Genitourinary Solid Tumors
1,274
Total downloads
4,781
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 24 Jan 2025
LncRNAs in serum-derived extracellular vesicles are potential biomarker and correlated with immune infiltration in gastric cancer
doi 10.3389/fimmu.2025.1533111
- 303 views
REVIEW
Published on 28 Nov 2024
Helicobacter pylori-targeted AI-driven vaccines: a paradigm shift in gastric cancer prevention
doi 10.3389/fimmu.2024.1500921
- 859 views
ORIGINAL RESEARCH
Published on 28 Nov 2024
Research on the effect of LAMP1 in the development and progression of ccRCC and its potential mechanism with LC3C-mediated autophagy
doi 10.3389/fimmu.2024.1494005
- 522 views
ORIGINAL RESEARCH
Published on 31 Oct 2024
In silico identification and verification of Tanshinone IIA-related prognostic genes in hepatocellular carcinoma
doi 10.3389/fimmu.2024.1482914
- 1,141 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 4,781Topic views
- 2,506Article views
- 1,274Article downloads